AI Articles and Analysis in Healthcare
Explore articles and analysis related to artificial intelligence in healthcare, including coverage of diagnostics, pharma, drug development, medical billing, and more.
While there have been and continue to be innovative and significant machine learning applications in healthcare, the industry has been slower to come to and embrace the big data movement than other industries. But a snail's pace hasn't kept the data from mounting, and the underlying value in the data now available to health care providers and related service providers is a veritable goldmine. In this editorial, we provide an overview of where healthcare's big data actually comes from, and why providing robust data analytics services in this sector matters.
As the term "machine learning" has heated up, interest in "robotics" (as expressed in Google Trends) has not altered much over the last three years. So how much of a place is there for machine learning in robotics?
Episode Summary: In this episode, we speak with Dr. Matteo Berlucchi, the founder of Your.MD, which uses artificial intelligence to create one of the first personal health assistant platforms in 70+ countries. Berlucchi talks about the challenges in making an AI do what you want, specifically helping people self diagnose and seek proper treatment. He discusses the multiple approaches to AI that are blended together in order to yield optimal results, and touches on the sometimes stark differences between what AI can do in the lab versus the functional application for tens of thousands of people. If you're interested in the diverse applications of AI and the challenges in running a startup, Dr. Berlucchi's makes for an interesting episode.
Autism Spectrum Disorder (ASD) is a developmental disability that affects a child's ability to communicate and interact with others. Symptoms also include repetitive behaviors and activities. The CDC estimates that 1 in 68 children are affected by ASD.
Tute Genomics is part of a grand shift towards the leveraging of genetic information towards better health and better treatments. One of the "holy grails" of this transition from one to the other is the advent of
If getting funding was easy, it wouldn't be called "getting funding."
Prospero Biosciences CEO Jonathan Rodriguez came on for an interview at Emerj to talk about his company and technology, as well as to shed some light on the real world experiences that a Biotech founder will face.